Related Experiment Video
Updated: Mar 9, 2026

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025
ASCO 2016: highlights in breast cancer
Rupert Bartsch1, Elisabeth Bergen1
1Comprehensive Cancer Center Vienna, Vienna, Austria ; Department of Medicine 1, Clinical Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.
Extended aromatase-inhibitor therapy for breast cancer showed marginal benefits but increased fractures. CDK 4/6 inhibitors like palbociclib significantly improved progression-free survival in metastatic breast cancer.
Area of Science:
- Oncology
- Breast Cancer Research
- Clinical Trials
Background:
- The 2016 ASCO Annual Meeting highlighted key advancements in breast cancer treatment.
- Ongoing research focuses on optimizing adjuvant therapies and novel treatments for metastatic disease.
Conclusions:
- Extended adjuvant AI therapy offers limited absolute benefit versus increased toxicity.
- CDK 4/6 inhibitors represent a significant advancement in first-line treatment for hormone receptor-positive metastatic breast cancer.
- Understanding resistance mechanisms, such as ESR1 mutations, is crucial for future treatment strategies.
More Related Videos
13:35Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
06:03Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
Published on: February 6, 2020
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Prevention
Some...
Cancer
Targeted Cancer Therapies
There are several types of targeted therapies against...